IkappaB kinase epsilon: a potential therapeutic target for obesity (and nonalcoholic fatty liver disease)?
Nelson
James E
JE
Benaroya Research Institute and Center for Liver Disease, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.
Kowdley
Kris V
KV